Abstract
Drugs which reduce plasma low-density lipoprotein cholesterol (LDL-C) may protect against gallstone disease. Whether plasma levels of LDL-C per se predict risk of gallstone disease remains unclear. We tested the hypothesis that elevated LDL-C is a causal risk factor for symptomatic gallstone disease.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Hepatology |
| Vol/bind | 58 |
| Udgave nummer | 1 |
| Sider (fra-til) | 126-33 |
| Antal sider | 8 |
| ISSN | 0168-8278 |
| DOI | |
| Status | Udgivet - 2013 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Low-density lipoprotein cholesterol and risk of gallstone disease: A Mendelian randomization study and meta-analyses'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS